Essa Pharma Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview

ESSA Pharma

07/02/2025 14:09

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on February 11
(estimated) for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for ESSA Pharma Inc is for a
loss
of 18 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $1.85​, above​ its last closing price of $1.70. ​​​

This summary was machine generated February 7 at 14:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)